Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Gabriel-Medina

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Biomedicines|May 28, 2022
Influence of Type 2 Diabetes in the Association of <i>PNPLA3</i> rs738409 and <i>TM6SF2</i> rs58542926 Polymorphisms in NASH Advanced Liver FibrosisPablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodriguez-Frias, et al.
Internal and Emergency Medicine|November 11, 2023
Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care levelPablo Gabriel-Medina, Roser Ferrer-Costa, Andreea Ciudin, et al.
Respiratory Research|December 10, 2022
New variants of alpha-1-antitrypsin: structural simulations and clinical expressionAngel Gonzalez, Irene Belmonte, Alexa Nuñez, et al.
Respiratory Medicine|August 26, 2023
Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumoniaAlexa Núñez, Cristina Aljama, Cristina Esquinas, et al.
Journal of Clinical Medicine|June 24, 2022
When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLDAlba Rojano-Toimil, Jesús Rivera-Esteban, Ramiro Manzano-Nuñez, et al.
Respiratory Research|September 16, 2021
Association between circulating alpha-1 antitrypsin polymers and lung and liver diseaseAlexa Núñez, Irene Belmonte, Elena Miranda, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2Noelia Díaz-Troyano, Pablo Gabriel-Medina, Stephen Weber, et al.
Journal of Clinical Biochemistry and Nutrition|March 28, 2025
Optimizing vitamin supplementation via reference interval update of vitamins A, E, B1, and B6 using HPLCAndrea Caballero, Gonzalo Gonzalez-Silva, Pablo Gabriel-Medina, et al.
Advances in Laboratory Medicine|June 26, 2023
Impact of SARS-CoV-2 infection on liver diseaseSergio Salgüero Fernández, Pablo Gabriel Medina, Alejandro Almería Lafuente, et al.
Journal of Clinical Medicine|December 9, 2023
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD StudyJesús Rivera-Esteban, Alba Jiménez-Masip, Sergio Muñoz-Martínez, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Biomedicines|May 28, 2022
Influence of Type 2 Diabetes in the Association of <i>PNPLA3</i> rs738409 and <i>TM6SF2</i> rs58542926 Polymorphisms in NASH Advanced Liver FibrosisPablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodriguez-Frias, et al.
Internal and Emergency Medicine|November 11, 2023
Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care levelPablo Gabriel-Medina, Roser Ferrer-Costa, Andreea Ciudin, et al.
Respiratory Research|December 10, 2022
New variants of alpha-1-antitrypsin: structural simulations and clinical expressionAngel Gonzalez, Irene Belmonte, Alexa Nuñez, et al.
Respiratory Medicine|August 26, 2023
Utility of the Enhanced Liver Fibrosis score as a blood biomarker of pulmonary fibrosis secondary to SARS-CoV-2 pneumoniaAlexa Núñez, Cristina Aljama, Cristina Esquinas, et al.
Journal of Clinical Medicine|June 24, 2022
When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLDAlba Rojano-Toimil, Jesús Rivera-Esteban, Ramiro Manzano-Nuñez, et al.
Respiratory Research|September 16, 2021
Association between circulating alpha-1 antitrypsin polymers and lung and liver diseaseAlexa Núñez, Irene Belmonte, Elena Miranda, et al.
Diagnostics (Basel, Switzerland)|April 23, 2022
Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2Noelia Díaz-Troyano, Pablo Gabriel-Medina, Stephen Weber, et al.
Journal of Clinical Biochemistry and Nutrition|March 28, 2025
Optimizing vitamin supplementation via reference interval update of vitamins A, E, B1, and B6 using HPLCAndrea Caballero, Gonzalo Gonzalez-Silva, Pablo Gabriel-Medina, et al.
Advances in Laboratory Medicine|June 26, 2023
Impact of SARS-CoV-2 infection on liver diseaseSergio Salgüero Fernández, Pablo Gabriel Medina, Alejandro Almería Lafuente, et al.
Journal of Clinical Medicine|December 9, 2023
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD StudyJesús Rivera-Esteban, Alba Jiménez-Masip, Sergio Muñoz-Martínez, et al.
Pageof 2